FENC — Fennec Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $383.89m
- $342.64m
- $44.64m
Brief: Fennec Pharmaceuticals Announces Second Closing Of $20 Million Investment From Petrichor
U.S. STOCKS ON THE MOVE-Freyr Battery, General Mills, Coty, ShiftPixy
U.S. STOCKS ON THE MOVE-ShiftPixy, Sesen Bio, U.S. airlines
U.S. STOCKS ON THE MOVE-Stitch Fix, Adamis Pharmaceuticals, Coty, Micron
Fennec up on U.S. approval of hearing loss therapy
Brief: Fennec Pharma Reports FDA Approval Of Pedmark
U.S. FDA approves Fennec's hearing loss therapy
Brief: Fennec Pharmaceuticals Closes First $5 Mln Investment From Petrichor
Brief: Fennec Pharmaceuticals reports Q2 results
Brief: Fennec Pharmaceuticals Announces Up To $45 Mln Investment From Petrichor
U.S. RESEARCH ROUNDUP-First Solar, Henry Schein, Petiq
Fennec Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: Fennec Pharmaceuticals Announces First Quarter 2022 Financial Results And Provides Business Update
Fennec Pharmaceuticals Inc expected to post a loss of 14 cents a share - Earnings Preview
Fennec Pharma up as FDA accepts resubmitted application for hearing loss drug
Brief: Fennec Pharmaceuticals Announces FDA Acceptance For Filing Of New Drug Application Resubmission For Pedmark
Brief: Fennec Pharmaceuticals Resubmits New Drug Application To U.S. Food And Drug Administration For Pedmark
Brief: Fennec Pharmaceuticals Announces Fiscal Year 2021 Financial Results And Provides Business Update
Brief: Fennec Pharmaceuticals Inc- Unit Of Co Entered Into Third Amendment To 2019 Loan And Security Agreement With Bridge Bank